| Year |
Citation |
Score |
| 2020 |
Deshmukh V, Seo T, Lauren O'Green A, Ibanez M, Hofilena B, Sunil KC, Stewart J, Dellamary L, Chiu K, Ghias A, Barroga C, Kennedy S, Tambiah J, Hood J, Yazici Y. SM04755, a Small-Molecule Inhibitor of the Wnt Pathway, as a Potential Topical Treatment for Tendinopathy. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. PMID 33104243 DOI: 10.1002/jor.24898 |
0.308 |
|
| 2020 |
Deshmukh V, Ibanez M, Hu H, Cahiwat J, Wei Y, Stewart J, Hood J, Yazici Y. A Small-Molecule Inhibitor of the Wnt Pathway, Lorecivivint (SM04690), as a Potential Disease-Modifying Agent for the Treatment of Degenerative Disc Disease. The Spine Journal : Official Journal of the North American Spine Society. PMID 32413487 DOI: 10.1016/J.Spinee.2020.04.024 |
0.316 |
|
| 2020 |
Deshmukh V, O’green A, Seo T, Yazici Y. Thu0056 Sm04755, A Potential Disease-Modifying Treatment For Tendinopathy, Modulates The Wnt Pathway Via Inhibition Of Clks And Dyrk1A Annals of the Rheumatic Diseases. 79: 239-240. DOI: 10.1136/Annrheumdis-2020-Eular.6625 |
0.416 |
|
| 2019 |
Tam BY, Chiu K, Chung H, Bossard C, Nguyen JD, Creger E, Eastman BW, Mak CC, Ibanez M, Ghias A, Cahiwat J, Do L, Cho S, Nguyen J, Deshmukh V, et al. The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models. Cancer Letters. PMID 31560935 DOI: 10.1016/J.Canlet.2019.09.009 |
0.34 |
|
| 2019 |
Deshmukh V, O'Green AL, Bossard C, Seo T, Lamangan L, Ibanez M, Ghias A, Lai C, Do L, Cho S, Cahiwat J, Chiu K, Pedraza M, Anderson S, Harris R, et al. Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment. Osteoarthritis and Cartilage. PMID 31132406 DOI: 10.1016/J.Joca.2019.05.006 |
0.311 |
|
| 2019 |
Deshmukh V, O’green A, Bossard C, Seo T, Lamangan L, Ibanez M, Ghias A, Lai C, Do L, Cho S, Cahiwat J, Chiu K, Pedraza M, Yazici Y. Op0072 Inhibition Of Clk2 And Dyrk1A By Sm04690 As A Novel Molecular Regulator Of Wnt Signaling, Chondrogenesis, And Inflammation, A Potential Disease-Modifying Treatment For Knee Osteoarthritis Annals of the Rheumatic Diseases. 78: 108-109. DOI: 10.1136/Annrheumdis-2019-Eular.5202 |
0.303 |
|
| 2018 |
Deshmukh V, Pedraza M, Lamangan L, Yazici Y. THU0046 Small molecule inhibitor of the wnt pathway (SM04755) as a potential topical treatment for psoriasis Annals of the Rheumatic Diseases. 77: 249-249. DOI: 10.1136/Annrheumdis-2018-Eular.4752 |
0.335 |
|
| 2018 |
Deshmukh V, Seo T, Hofilena B, Dellamary L, Yazici Y. Experimental tendinopathy treatment with SM04755, a topical small molecule inhibitor of the WNT pathway Osteoarthritis and Cartilage. 26. DOI: 10.1016/J.Joca.2018.02.064 |
0.311 |
|
| 2018 |
Deshmukh V, Pedraza M, Lamangan L, Yazici Y. 1097 Small molecule Wnt pathway inhibitor (SM0755) as a potential topical treatment for psoriasis Journal of Investigative Dermatology. 138. DOI: 10.1016/J.Jid.2018.03.1110 |
0.318 |
|
| 2018 |
Deshmukh V, Pedraza M, Tran L, Duong-Polk K, Ghias A, Dellamary L, Melchior B, Yazici Y. Small molecule inhibitor of the Wnt pathway (SM04755) as a potential topical treatment for psoriasis Journal of the American Academy of Dermatology. 79. DOI: 10.1016/J.Jaad.2018.05.1044 |
0.318 |
|
| 2017 |
Deshmukh V, Hu H, Barroga C, Bossard C, Kc S, Dellamary L, Stewart J, Chiu K, Ibanez M, Pedraza M, Seo T, Do L, Cho S, Cahiwat J, Tam B, et al. A Small Molecule Inhibitor of the Wnt Pathway (SM04690) As a Potential Disease Modifying Agent for the Treatment of Osteoarthritis of the Knee. Osteoarthritis and Cartilage. PMID 28888902 DOI: 10.1016/J.Joca.2017.08.015 |
0.31 |
|
| 2017 |
Deshmukh V, Seo T, Ibanez M, Stewart J, Hofilena B, Yazici Y. SAT0607 Discovery of a small molecule inhibitor of the WNT pathway (SM04755) as a potential topical treatment for tendinopathy Annals of the Rheumatic Diseases. 76: 1003-1004. DOI: 10.1136/Annrheumdis-2017-Eular.6427 |
0.361 |
|
| 2017 |
Barroga C, Deshmukh V, Kc S, Dellamary L, Hood J, Steward J, Hu H, Yazici Y. Discovery of a small molecule inhibitor of the Wnt pathway (SM04690) as a potential treatment for degenerative disc disease Osteoarthritis and Cartilage. 25. DOI: 10.1016/J.Joca.2017.02.688 |
0.32 |
|
| 2017 |
Deshmukh V, Barroga C, Ibanez M, Seo T, Kc S, Dellamary L, Stewart J, Yazici Y. Anti-inflammatory Properties of SM04690, a Small Molecule Inhibitor of the Wnt Pathway as a Potential Treatment for Knee Osteoarthritis Osteoarthritis and Cartilage. 25. DOI: 10.1016/J.Joca.2017.02.520 |
0.331 |
|
| 2017 |
Deshmukh V, Seo T, Ibanez M, Hofilena B, Kc S, Dellamary L, Stewart J, Hood J, Yazici Y. Discovery of a Small Molecule Inhibitor of The Wnt Pathway (SM04755) as a Potential Topical Treatment for Tendinopathy Osteoarthritis and Cartilage. 25. DOI: 10.1016/J.Joca.2017.02.474 |
0.323 |
|
| 2017 |
Deshmukh V, Pedraza M, Ibanez M, Yazici Y. 711 Small molecule wnt pathway inhibitor (SM04755) as a potential topical psoriasis treatment Journal of Investigative Dermatology. 137. DOI: 10.1016/J.Jid.2017.02.734 |
0.318 |
|
| 2016 |
Hood J, Barroga C, Hu Y, Deshmukh V. OP0069 Discovery of A Small Molecule Inhibitor of The WNT Pathway (SM04690) as A Potential Disease Modifying Treatment for Knee Osteoarthritis Annals of the Rheumatic Diseases. 75: 81-81. DOI: 10.1136/Annrheumdis-2016-Eular.2386 |
0.337 |
|
| 2016 |
Hood JD, Deshmukh V, Barroga C, Hu Y. Discovery of a small molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying treatment for knee osteoarthritis Osteoarthritis and Cartilage. 24. DOI: 10.1016/J.Joca.2016.01.055 |
0.315 |
|
| 2015 |
Wang RE, Liu T, Wang Y, Cao Y, Du J, Luo X, Deshmukh V, Kim CH, Lawson BR, Tremblay MS, Young TS, Kazane SA, Wang F, Schultz PG. An immunosuppressive antibody-drug conjugate. Journal of the American Chemical Society. 137: 3229-32. PMID 25699419 DOI: 10.1021/Jacs.5B00620 |
0.7 |
|
| 2014 |
Kularatne SA, Deshmukh V, Ma J, Tardif V, Lim RK, Pugh HM, Sun Y, Manibusan A, Sellers AJ, Barnett RS, Srinagesh S, Forsyth JS, Hassenpflug W, Tian F, Javahishvili T, et al. A CXCR4-targeted site-specific antibody-drug conjugate. Angewandte Chemie (International Ed. in English). 53: 11863-7. PMID 25213874 DOI: 10.1002/Anie.201408103 |
0.762 |
|
| 2014 |
Lu H, Zhou Q, Deshmukh V, Phull H, Ma J, Tardif V, Naik RR, Bouvard C, Zhang Y, Choi S, Lawson BR, Zhu S, Kim CH, Schultz PG. Targeting human C-type lectin-like molecule-1 (CLL1) with a bispecific antibody for immunotherapy of acute myeloid leukemia. Angewandte Chemie (International Ed. in English). 53: 9841-5. PMID 25056598 DOI: 10.1002/Anie.201405353 |
0.786 |
|
| 2013 |
Kularatne SA, Deshmukh V, Gymnopoulos M, Biroc SL, Xia J, Srinagesh S, Sun Y, Zou N, Shimazu M, Pinkstaff J, Ensari S, Knudsen N, Manibusan A, Axup JY, Kim CH, et al. Recruiting cytotoxic T cells to folate-receptor-positive cancer cells. Angewandte Chemie (International Ed. in English). 52: 12101-4. PMID 24573789 DOI: 10.1002/Anie.201306866 |
0.726 |
|
| 2013 |
Deshmukh VA, Tardif V, Lyssiotis CA, Green CC, Kerman B, Kim HJ, Padmanabhan K, Swoboda JG, Ahmad I, Kondo T, Gage FH, Theofilopoulos AN, Lawson BR, Schultz PG, Lairson LL. A regenerative approach to the treatment of multiple sclerosis. Nature. 502: 327-32. PMID 24107995 DOI: 10.1038/Nature12647 |
0.71 |
|
| 2013 |
Swoboda JG, Elliott J, Deshmukh V, de Lichtervelde L, Shen W, Tremblay MS, Peters EC, Cho CY, Lu B, Girman S, Wang S, Schultz PG. Small molecule mediated proliferation of primary retinal pigment epithelial cells. Acs Chemical Biology. 8: 1407-11. PMID 23621521 DOI: 10.1021/Cb4001712 |
0.674 |
|
| 2013 |
Shen W, Tremblay MS, Deshmukh VA, Wang W, Filippi CM, Harb G, Zhang YQ, Kamireddy A, Baaten JE, Jin Q, Wu T, Swoboda JG, Cho CY, Li J, Laffitte BA, et al. Small-molecule inducer of β cell proliferation identified by high-throughput screening. Journal of the American Chemical Society. 135: 1669-72. PMID 23330637 DOI: 10.1021/Ja309304M |
0.729 |
|
| Show low-probability matches. |